DUBLIN, June 6, 2013 /PRNewswire/ --
Research and Markets (http://www.researchandmarkets.com/research/qs2bc8/closed_drug) has announced the addition of the "Closed Drug Transfer Systems. Therapeutic Markets, Strategies and Outlook" report to their offering.
The administration of drugs deemed hazardous to humans has been receiving increasing amounts of scrutiny in recent years as the dangers of these substances become more clearly understood.
For caregivers and their patients, the therapeutic area that is at the forefront of attempts to mitigate exposure to cytotoxic drugs is clinical oncology, a field that - in spite of promising new drugs based on therapeutic antibodies - continues to rely heavily on antineoplastics, a class that includes alkylating agents and antimetabolites, to treat a wide range of cancers. Regulatory and industry efforts to create standards and procedures designed to protect workers and patients from accidental and incidental exposure to cytotoxics are being driven by data that suggests a causal link between exposure and health issues. Studies of nurses who work with cytotoxic drugs on a regular basis have found a statistically higher rate of spontaneous abortion.
Several companies are responding to this unmet need by commercializing devices for closed transfer of these drugs. As the market evolves and user acceptance increases, so too will the impact of these products on oncology therapy protocols and drug delivery.
- Analyzes the impact of drug toxicity and safety factors on therapeutic oncology market segments, market dynamics and market demographics
- Provides detailed analysis of closed drug transfer products for the handing of cytotoxic drugs
- Analyzes demand drivers and competitive factors influencing closed drug transfer adoption
- Charts product data and provides forecasts to 2017
- Profiles closed drug transfer device participants, their product development activities, business strategies, and corporate alliances and affiliations
Key Topics Covered:
Oncology Therapeutics Market Dynamics
Therapeutic Trends and Issues
The Administration of injectable/Infusable Antineoplastics
Drug Packaging and Administration Technology
Closed Drug Transfer Market Drivers
Closed Drug Transfer Design Factors
Key System Design Elements
Material Selection Issues
Drug Reconstitution and Dilution
Oncology Therapeutics Medication Safety
Oncology Drug Administration and Dosing
Drug-Specific Dosing Modification and Individualized Dosing
Closed Drug Transfer - Commercial Device Assessments and Market Data
Level of Complexity and Ease of Use
Business Models and Strategies
Market Assessments and Forecasts
Other Geographic Markets
Closed Drug Transfer - Market Participant Profiles
For more information visit http://www.researchandmarkets.com/research/qs2bc8/closed_drug
About Research and Markets
Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
|SOURCE Research and Markets|
Copyright©2012 PR Newswire.
All rights reserved